Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH SUVEN LIFE SCIENCES PANACEA BIOTECH/
SUVEN LIFE SCIENCES
 
P/E (TTM) x -60.9 -20.5 - View Chart
P/BV x 0.9 5.8 15.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PANACEA BIOTECH   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
SUVEN LIFE SCIENCES
Mar-23
PANACEA BIOTECH/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs19194 204.1%   
Low Rs10745 238.1%   
Sales per share (Unadj.) Rs75.10.6 12,095.1%  
Earnings per share (Unadj.) Rs-5.5-5.4 101.6%  
Cash flow per share (Unadj.) Rs0.9-5.1 -17.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs137.717.2 800.3%  
Shares outstanding (eoy) m61.25218.07 28.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.0111.8 1.8%   
Avg P/E ratio x-27.1-12.8 211.7%  
P/CF ratio (eoy) x170.0-13.5 -1,255.1%  
Price / Book Value ratio x1.14.0 26.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m9,14215,131 60.4%   
No. of employees `000NANA-   
Total wages/salary Rs m1,265186 679.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,599135 3,397.2%  
Other income Rs m51784 611.5%   
Total revenues Rs m5,116220 2,326.8%   
Gross profit Rs m47-1,196 -3.9%  
Depreciation Rs m39165 597.9%   
Interest Rs m445 824.7%   
Profit before tax Rs m128-1,183 -10.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4660-   
Profit after tax Rs m-337-1,183 28.5%  
Gross profit margin %1.0-883.6 -0.1%  
Effective tax rate %363.50-   
Net profit margin %-7.3-873.5 0.8%  
BALANCE SHEET DATA
Current assets Rs m5,6233,455 162.8%   
Current liabilities Rs m3,2971,050 313.9%   
Net working cap to sales %50.61,776.0 2.8%  
Current ratio x1.73.3 51.8%  
Inventory Days Days593,948 1.5%  
Debtors Days Days48218 21.9%  
Net fixed assets Rs m7,0281,373 511.8%   
Share capital Rs m61218 28.1%   
"Free" reserves Rs m8,3753,535 236.9%   
Net worth Rs m8,4363,753 224.8%   
Long term debt Rs m2020-   
Total assets Rs m12,7124,828 263.3%  
Interest coverage x3.9-218.8 -1.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40 1,290.3%   
Return on assets %-2.3-24.4 9.5%  
Return on equity %-4.0-31.5 12.7%  
Return on capital %2.0-31.4 -6.4%  
Exports to sales %43.340.4 107.1%   
Imports to sales %24.4839.8 2.9%   
Exports (fob) Rs m1,99255 3,638.8%   
Imports (cif) Rs m1,1241,137 98.8%   
Fx inflow Rs m1,99255 3,638.8%   
Fx outflow Rs m1,1911,137 104.7%   
Net fx Rs m801-1,082 -74.0%   
CASH FLOW
From Operations Rs m-4,225-1,031 409.6%  
From Investments Rs m4,303-2,606 -165.1%  
From Financial Activity Rs m-1843,955 -4.6%  
Net Cashflow Rs m-105317 -33.1%  

Share Holding

Indian Promoters % 73.6 69.6 105.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 0.6 172.7%  
FIIs % 0.3 0.5 48.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 30.4 86.8%  
Shareholders   47,091 74,003 63.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs Suven Life Sciences Share Price Performance

Period Panacea Biotech Suven Life Sciences S&P BSE HEALTHCARE
1-Day -1.74% 0.30% 1.18%
1-Month -20.01% -2.06% -0.75%
1-Year 11.75% 114.92% 61.82%
3-Year CAGR -12.26% 14.94% 18.16%
5-Year CAGR -9.98% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.